Research of the EML4-ALK Gene Expression in the Pleural Effusion or Tumor Tissue From Lung Cancer Patients
N/A
20 Years
N/A
20 Years
N/A
Open (Enrolling by invite only)
Both
Lung Cancer Patients
Both
Lung Cancer Patients
Trial Information
Research of the EML4-ALK Gene Expression in the Pleural Effusion or Tumor Tissue From Lung Cancer Patients
Inclusion Criteria:
- 20 or more than 20 years of age
- The pathological diagnosis confirmed lung cancer
- Patients have achieved pleural effusion, or surgical biopsy to obtain tumor tissue
specimens
- The patient had signed inform consent
Exclusion Criteria:
- pleural effusion or tumor tissue can not be obtained
- the patient is not suitable to join the research according to the judgement by the
investigator
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Principal Investigator
Hsin-Gjin Eugene Liu
Investigator Role:
Principal Investigator
Investigator Affiliation:
Taipei Medical University WanFang Hospital
Authority:
Taiwan: Department of Health
Study ID:
99047
NCT ID:
NCT01257308
Start Date:
August 2010
Completion Date:
August 2013
Related Keywords:
- Lung Cancer Patients
- lung cancer
- Lung Neoplasms
- Pleural Effusion
Name | Location |
|---|
